0001140361-17-010393.txt : 20170302 0001140361-17-010393.hdr.sgml : 20170302 20170302213218 ACCESSION NUMBER: 0001140361-17-010393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170228 FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Havey Adam CENTRAL INDEX KEY: 0001514588 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 17661365 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20853 4 1 doc1.xml FORM 4 X0306 4 2017-02-28 0 0001367644 Emergent BioSolutions Inc. EBS 0001514588 Havey Adam 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Biodefense Divison Common Stock 2017-02-28 4 A 0 4285 0.00 A 38618 D Common Stock 2017-02-28 4 A 0 4285 0.00 A 42903 D Common Stock 2017-02-28 4 F 0 938 30.63 D 41965 D Employee Stock Option (right to buy 30.63 2017-02-28 4 A 0 17134 30.63 A 2024-02-27 Common Stock 17134 17134 D Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2019 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period. Vests in three equal installments on February 27, 2018, February 27, 2019 and February 27, 2020. /s/ Eric Burt, Attorney-in-fact 2017-03-02